Absci (ABSI) Preferred Dividend Payments (2020 - 2021)

Absci's (ABSI) quarterly Preferred Dividend Payments came in at $242000.0 in Q3 2021, down 76.89% quarter-over-quarter from $1.0 million in Q2 2021.

Absci (ABSI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

Absci has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $242000.0 for Q3 2021.

Preferred Dividend Payments for Q3 2021 came in at $242000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $242000.0 (down 99.33% YoY), and the FY2021 annual result was $2.3 million, down 93.35% from the prior year.
Preferred Dividend Payments came in at $242000.0 for Q3 2021 at Absci, down from $1.0 million in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $34.3 million in Q4 2020 to a low of $242000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Absci	1.13 Bn	1.01 Bn	-	-

Download Data